Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Planned sale Director sold 19,732 shares at an average $34.14 ($673,748)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 144 Insider Sale of Securities
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Other events
  13. 424B5 Offering Prospectus
  14. 8-K Event Results of operations
  15. 10-Q Report Quarterly Report
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 4 Planned sale Director sold 13,535 shares at an average $35.16 ($475,879)
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Planned sale Director sold 36,684 shares at an average $35.29 ($1,294,437)

Page 16 of 40 · 796 filings